Guelfi, Julien Daniel

Reducing the treatment gap for mental disorders: a WPA survey

PATEL, V., MAJ, M., FLISHER, A. J., DE SILVA, M. J., KOSCHORKE, M., PRINCE, M., WPA Zonal and Member Society Representatives, Tempier, R., Riba, M., Sanchez, M., et al. (2010) · World Psychiatry

Mental Health Treatment and AccessPsychiatric care and mental health services

Cited by 420

Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features

Guelfi, J. D., Ansseau, M., Timmerman, L., & Kørsgaard, S. (2001) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionPsychological Treatments and Disorders

Cited by 138

Anhedonia and blunted affect in major depressive disorder

Loas, G., Salinas, E., Pierson, A., Guelfi, J. D., & Samuel-Lajeunesse, B. (1994) · Comprehensive Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 48

Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder: Results of a Randomized Trial

Rickels, K., Montgomery, S. A., Tourian, K. A., Guelfi, J. D., Pitrosky, B., Padmanabhan, S. K., Germain, J.-M., Leurent, C., & Brisard, C. (2010) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 33